Sanara Medtech Applied Technologies, LLC – Trademark Portfolio
Entity Type: 16
Sanara Medtech Applied Technologies, LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include HYCURE, COLLAMIN, REPAIRRX, and CELLERATE RX. The owner is based in Fort Worth, TX.
1200 Summit Avenue
Fort Worth, TX 76102
Showing of trademarks Trademarks
Trademark Classifications
Sanara Medtech Applied Technologies, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Sanara Medtech Applied Technologies, LLC have?
Sanara Medtech Applied Technologies, LLC has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.
What trademark classes does Sanara Medtech Applied Technologies, LLC file in?
Sanara Medtech Applied Technologies, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Sanara Medtech Applied Technologies, LLC's most well-known trademarks?
Sanara Medtech Applied Technologies, LLC's registered trademark portfolio includes well-known marks such as HYCURE, COLLAMIN, REPAIRRX, and CELLERATE RX. These are among 5 currently registered trademarks in the portfolio.
What is Sanara Medtech Applied Technologies, LLC's trademark registration success rate?
Sanara Medtech Applied Technologies, LLC has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.